Trevi Therapeutics logo

Trevi Therapeutics jobs and careers

New Haven, CT, United States

About Trevi Therapeutics

Trevi is a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions.

Founded in 2011 by Jennifer L. Good and Thomas R. Sciascia.

Founded
2011
Employees
11 to 50
Total funding
$156.5M
Headquarters
New Haven

Leadership

The top of Trevi Therapeutics's org chart, with how many people report into each leader.

JGPhoto of Jennifer Good

Jennifer Good

President and CEO

20 reports

DCPhoto of David Clark

David Clark

Chief Medical Officer

8 reports

CCPhoto of Christopher Galletta, CPA

Christopher Galletta, CPA

Controller

2 reports

FSPhoto of Farrell Simon

Farrell Simon

Chief Commercial Officer

2 reports

RV

Ralph Vaccaro

Senior Director, Information Technology

1 report

RD

Rebecca Drain

Vice President, Global Regulatory Affairs

KTPhoto of Katherine Takaki

Katherine Takaki

VP, Global Regulatory Affairs

TSPhoto of Thomas Sciascia

Thomas Sciascia

Co-Founder, Chief Science Officer

Board

DC

Dominick Colangelo

Board Member

EM

Ed Mathers

Board Member

JCPhoto of James Cassella

James Cassella

Chief Development Officer (cdo)

MHPhoto of Michael Heffernan

Michael Heffernan

Lead Independent Director

AVPhoto of Anne Vanlent

Anne Vanlent

Member Board Of Directors. Audit Committee Chair

DM

David Meeker

Chairman